Sorry, you need to enable JavaScript to visit this website.

18F-Sodium Fluoride PET/CT Bone Imaging in Patients With Castration-Resistant Prostate Cancer and Bone Metastases

A Phase 2, Open-Label, Single-Arm Study of 18F-Sodium Fluoride PET/CT Bone Imaging in Enzalutamide-Treated Chemotherapy-Naïve Patients With Bone-Metastatic Castration-Resistant Prostate Cancer

Category & Conditions: Cancer
Medicine: Xtandi (enzalutamide)
ClinicalTrials.gov Identifier (NCT): NCT02384382
Protocol ID: C3431012
    Share
PrintDownload
Open Plain Language Summary Result: Click here